Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy

Authors

  • Ji-Nuo Wang Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Yu Qiu Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Na Niu Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Yan Zhang Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Jian Li Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Dao-bin Zhou Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Xin-Xin Cao Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

DOI:

https://doi.org/10.1080/0284186X.2019.1670355

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2020-03-03

How to Cite

Wang, J.-N., Qiu, Y., Niu, N., Zhang, Y., Li, J., Zhou, D.- bin, & Cao, X.-X. (2020). Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy. Acta Oncologica, 59(3), 302–305. https://doi.org/10.1080/0284186X.2019.1670355

Issue

Vol. 59 No. 3 (2020): Acta Oncologica

Section

Articles